Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2001 Oct;6(4):337-44.
doi: 10.1379/1466-1268(2001)006<0337:AMHPSN>2.0.CO;2.

A 14-mer Hsp70 peptide stimulates natural killer (NK) cell activity

Affiliations
Comparative Study

A 14-mer Hsp70 peptide stimulates natural killer (NK) cell activity

G Multhoff et al. Cell Stress Chaperones. 2001 Oct.

Abstract

Compared with normal cells, tumor cell lines exhibit an unusual plasma membrane localization of heat shock protein 70 (Hsp70). This tumor-selective Hsp70 membrane expression has been found to correlate with an increased sensitivity to lysis mediated by human natural killer (NK) cells that transiently adhere to plastic following cytokine stimulation. A human Hsp70-specific monoclonal antibody (mAb) detects membrane-bound Hsp70 on viable tumor cells and blocks the immune response of NK cells against Hsp70-expressing tumor cells. By peptide scanning (pep-scan) analysis, the epitope of this mAb was mapped as the C-terminal-localized 8-mer NLLGRFEL (NLL, amino acids [aa] 454-461). Most interestingly, similar to full-length Hsp70 protein, the N-terminal-extended 14-mer peptide TKDNNLLGRFELSG (TKD, aa 450-463) was able to stimulate the cytolytic and proliferative activity of NK cells at concentrations equivalent to full-length Hsp70 protein. Blocking studies revealed that an excess of the 14-mer peptide TKDNNLLGRFELSG inhibits the cytolytic activity of NK cells similar to that of Hsp70 protein. In comparison, other TKD-related peptides, including the 8-mer antibody epitope NLLGRFEL (aa 454-461), the 12-mer TKDNNLLGRFEL (aa 450-461), the 13-mer C-terminal-extended peptide NLLGRFELSGIPP (aa 454-466), the 14-mer TKD-equivalent sequences of Hsp70hom TKDNNLLGRFELTG (aa 450-463), Hsc70 TKDNNLLGKFELTG (aa 450-463), and DnaK AADNKSLGQFNLDG (aa 447-460) failed to activate NK activity.

PubMed Disclaimer

Figures

Fig. 2.
Fig. 2.
Comparison of the proliferative response of NK cells against different Hsp70 peptides. NK cells were stimulated either with IL-2 (100 IU/mL) alone or with IL-2 plus peptides GIPP (13-mer), NLL (8-mer), TKD (14-mer), TKD12 (12-mer), HSC70 (14-mer), HOM (14-mer), and DNAK (14 mer) at a concentration of 2 μg/mL. The proliferative response of NK cells was measured 48 hours after peptide incubation and an 18-hour incubation period with 3H thymidine (0.5 μCi/mL). Values are given as the means of 2 independent experiments ± SD
Fig. 3.
Fig. 3.
Cytolytic activity of NK cells either stimulated with low-dose IL-2 (100 IU/mL) alone or with IL-2 plus the 14-mer peptide TKD (2 μg/mL) or with IL-2 plus the 8-mer peptide NLL (2 μg/mL) for 4 days. As target cells, 51Cr-labeled CX+ and CX− tumor cells, which differ with respect to their capability to express Hsp70 on the plasma membrane, were used. The results are expressed as the percentage of specific lysis at varying E:T ratios ranging from 1:1 to 40:1. The percentage of spontaneous release for each tumor target cell line was less than 20%. A phenotypic characterization of the NK cells reveals the following: NK cells plus TKD: CD3, 4%; CD16/56, 83%; NK cells plus NLL: CD3, 6%; CD16/56, 80%; NK cells: CD3, 3%; CD16/56, 84%. The data represent 1 representative experiment of 4
Fig. 4.
Fig. 4.
Blocking of the cytolytic activity of low-dose IL-2 (100 IU/mL) stimulated NK cells (CD16/56, 49%) against CX+ and CX− tumor cells either by incubation of the target cells with Hsp70 mAb (10 μg/1 × 106 cells) or by incubation of NK cells with TKD peptide (10 μg/mL) for 30 minutes at room temperature, directly before the assay. The data represent 1 representative experiment of 3
Fig. 1.
Fig. 1.
(A) Comparison of the proliferative response of NK cells against Hsp70 peptides. NK cells were stimulated either with IL-2 (100 IU/mL) alone or with IL-2 plus peptides NLL (8-mer), TKD (14-mer), and GIPP (13-mer) at concentrations of 0.02, 0..2, 2, 4, and 8 μg/mL. NK cells were also stimulated with rHsp70 protein at a concentration of 10 and 200 μg/mL, respectively. The proliferative response of NK cells was measured 72 hours after peptide incubation and an 18-hour incubation period with 3H thymidine (0.5 μCi/mL). Values are given as the means of 5 independent experiments ± SD. (B) To evaluate the optimal stimulatory dose of TKD (14-mer), an extended concentration range was tested: NK cells were stimulated either with IL-2 (100 IU/mL) alone or with IL-2 plus peptides TKD (14-mer) at the following concentrations 0.1, 0.2, 0.5, 1, 1.5, 2.5, and 3 μg/mL. The proliferative response of NK cells was measured 48 hours after peptide incubation and an 18-hour incubation period with 3H thymidine (0.5 μCi/mL). Values are given as the means of 3 independent experiments ± SD
Fig. 1.
Fig. 1.
Continued

Similar articles

Cited by

References

    1. Altmeyer A, Maki RG, Feldweg AM, Heike M, Protopopov VP, Masur SK, Srivastava PK. Tumor-specific cell surface expression of the -KDEL containing, endoplasmic reticular heat shock protein gp96. Int J Cancer. 1996;69:340–349. - PubMed
    1. Arnold-Schild D, Hanau D, Spehner D, Schmid C, Rammensee H-J, Salle EH, Schild H-J. Receptor-mediated endocytosis of hsp by professional antigen-presenting cells. J Immunol. 1999;162:3757–3760. - PubMed
    1. Asea A, Kraeft S-K, Kurt-Jones EA, Stevenson MA, Chen LB, Finberg RW, Koo GC, Calderwood SK. Hsp70 stimulates cytokine production through a CD14-dependent pathway, demonstrating its dual role as a chaperone and cytokine. Nat Med. 2000;6:435–442. - PubMed
    1. Basu RJ, Binder RJ, Ramalingam T, Srivastava PK. CD91: a receptor for heat shock protein gp96. Immunity. 2001;8:303–313. - PubMed
    1. Binder RJ, Han DK, Srivastava PK. CD91: a receptor for heat shock protein gp96. Nat Immunol. 2000a;1:151–156. - PubMed

Publication types

MeSH terms

LinkOut - more resources